Wednesday, Jan. 20, 2016, CLEVELAND: Melanoma, the deadliest form of skin cancer, is on the rise in women of child-bearing age. Those at the greatest risk, according to new Cleveland Clinic research, are women younger than 50 who are pregnant or have recently been pregnant.
Scientific Publications
Nivolumab, Contact Immunotx Treats In-Transit Melanoma
Nivolumab in combination with contact immunotherapy can successfully treat in-transit melanoma, according to two case reports published online Dec. 12 in the Journal of Dermatology
Physicians may soon have new tool to closely track severity, potential spread of metastatic melanoma
Physicians treating patients with metastatic melanoma — one of the most aggressive forms of skin cancer — may soon have a superior tool in their efforts to closely track the disease.
Combination Shown to Successfully Treat In-Transit Melanoma
HealthDay News — Nivolumab in combination with contact immunotherapy can successfully treat in-transit melanoma, according to two case reports published online December 12 in the Journal of Dermatology.